Recent Posts
- Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca
- Inalve raises 2m€ to accelerate the aquaculture transition toward a more sustainable industry
- Amolyt Pharma Named ‘Biotech Company of the Year” at the LSX European Lifestars Awards
- Greentech: MECAWARE secures €40m to become the leader in battery recycling and the production of strategic metals in France and Europe
- Amolyt Pharma to Present Data on the Renal Effects of Eneboparatide, a PTHR1 Agonist in Phase 3 for the Treatment of Hypoparathyroidism, at the 39th Congress of the French Society of Endocrinology
Archives
- March 2024
- December 2023
- November 2023
- October 2023
- September 2023
- June 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- October 2022
- September 2022
- August 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- October 2021
- September 2021
- August 2021
- July 2021
- May 2021
- April 2021
- March 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- July 2020
- April 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- July 2019
- March 2019
- February 2019
- December 2018
- November 2018
- December 2017
- September 2017
- April 2017